1. Home
  2. INMB

INMB

INmune Bio Inc. Common stock

Logo INmune Bio Inc. Common stock

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-12-2024 4:00pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products includeINKmune, INBO3, XPro1595, LIVNate, and others.

Founded: 2015 Country:
United States
United States
Employees: N/A City: BOCA RATON
Market Cap: 195.4M IPO Year: 2019
Target Price: $16.00 AVG Volume (30 days): 84.0K
Analyst Decision: Buy Number of Analysts: 1
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.67 EPS Growth: N/A
52 Week Low/High: $6.50 - $14.74 Next Earning Date: 05-01-2024
Revenue: $155,000 Revenue Growth: -58.56%
Revenue Growth (this year): -27.61% Revenue Growth (next year): 9.09%

Share on Social Networks: